CareLit · DOI-Nachweis · Aktuelle Neurologie
Cabergoline versus pergolide in levodopa-treated Parkinson's disease patients with nocturnal disabilities: a randomised, double-blind crossover trial to evaluate efficacy, tolerability, and quality of life
DOI 10.1055/s-2004-833290
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Trenkwalder, M Canelo, A Forbes, M Leroux, R Chaudhuri
ZeitschriftAktuelle Neurologie
Ausgabe09/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Sleep disorders in PD patients often are caused by complications of levodopa therapy like motor fluctuations in response or abnormal involuntary movements. These may appear as early morning dystonia, pain and spasm at night, nocturnal akinesia, nocturia and nocturnal treatment-related psychotic episodes, namely hallucinations. Method: In a double-blind, randomised, bi-centre, crossover design, patients with idiopath…
Zitieren
Zitierempfehlung
C Trenkwalder, M Canelo, A Forbes, M Leroux, R Chaudhuri (2004) Cabergoline versus pergolide in levodopa-treated Parkinson's disease patients with nocturnal disabilities: a randomised, double-blind crossover trial to evaluate efficacy, tolerability, and quality of life. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2004-833290
Mit CareLit weiterarbeiten